Acurx Pharmaceuticals, Inc. (ACXP) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $5.27M | +756.5% |
| 2024 | $615.1K | -86.8% |
| 2023 | $4.67M | -36.2% |
| 2022 | $7.32M | -41.1% |
| 2021 | $12.41M | +359.4% |
| 2020 | $2.70M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $5.27M | +756.5% |
| 2024 | $615.1K | -86.8% |
| 2023 | $4.67M | -36.2% |
| 2022 | $7.32M | -41.1% |
| 2021 | $12.41M | +359.4% |
| 2020 | $2.70M | — |